Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose of INCMGA00012 in combination with common standard-of-care chemotherapy regimens in participants with advanced solid tumors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Advanced and/or Metastatic Solid Tumors
  • Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma
  • Carcinoma, Non-Small-Cell Lung
  • Mesothelioma
  • Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer

NCT number NCT03920839
Study type Interventional
Source Incyte Corporation
Contact
Status Withdrawn
Phase Phase 1
Start date July 15, 2019
Completion date November 4, 2019